1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Melanoma Cancer Revenue
1.4 Market by Type
1.4.1 Global Melanoma Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Non-invasive melanoma
1.4.3 Invasive melanoma
1.5 Market by Application
1.5.1 Global Melanoma Cancer Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Cancer Research Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Cancer Market Perspective (2015-2026)
2.2 Global Melanoma Cancer Growth Trends by Regions
2.2.1 Melanoma Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Melanoma Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Melanoma Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Melanoma Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Melanoma Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Cancer Players by Market Size
3.1.1 Global Top Melanoma Cancer Players by Revenue (2015-2020)
3.1.2 Global Melanoma Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Melanoma Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Melanoma Cancer Market Concentration Ratio
3.2.1 Global Melanoma Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Melanoma Cancer Revenue in 2019
3.3 Melanoma Cancer Key Players Head office and Area Served
3.4 Key Players Melanoma Cancer Product Solution and Service
3.5 Date of Enter into Melanoma Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Melanoma Cancer Historic Market Size by Type (2015-2020)
4.2 Global Melanoma Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Melanoma Cancer Market Size by Application (2015-2020)
5.2 Global Melanoma Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Melanoma Cancer Market Size (2015-2020)
6.2 Melanoma Cancer Key Players in North America (2019-2020)
6.3 North America Melanoma Cancer Market Size by Type (2015-2020)
6.4 North America Melanoma Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Melanoma Cancer Market Size (2015-2020)
7.2 Melanoma Cancer Key Players in Europe (2019-2020)
7.3 Europe Melanoma Cancer Market Size by Type (2015-2020)
7.4 Europe Melanoma Cancer Market Size by Application (2015-2020)
8 China
8.1 China Melanoma Cancer Market Size (2015-2020)
8.2 Melanoma Cancer Key Players in China (2019-2020)
8.3 China Melanoma Cancer Market Size by Type (2015-2020)
8.4 China Melanoma Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Melanoma Cancer Market Size (2015-2020)
9.2 Melanoma Cancer Key Players in Japan (2019-2020)
9.3 Japan Melanoma Cancer Market Size by Type (2015-2020)
9.4 Japan Melanoma Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Melanoma Cancer Market Size (2015-2020)
10.2 Melanoma Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Melanoma Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Melanoma Cancer Market Size by Application (2015-2020)
11 India
11.1 India Melanoma Cancer Market Size (2015-2020)
11.2 Melanoma Cancer Key Players in India (2019-2020)
11.3 India Melanoma Cancer Market Size by Type (2015-2020)
11.4 India Melanoma Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Melanoma Cancer Market Size (2015-2020)
12.2 Melanoma Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Melanoma Cancer Market Size by Type (2015-2020)
12.4 Central & South America Melanoma Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AB Sciences
13.1.1 AB Sciences Company Details
13.1.2 AB Sciences Business Overview
13.1.3 AB Sciences Melanoma Cancer Introduction
13.1.4 AB Sciences Revenue in Melanoma Cancer Business (2015-2020))
13.1.5 AB Sciences Recent Development
13.2 Incyte
13.2.1 Incyte Company Details
13.2.2 Incyte Business Overview
13.2.3 Incyte Melanoma Cancer Introduction
13.2.4 Incyte Revenue in Melanoma Cancer Business (2015-2020)
13.2.5 Incyte Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Melanoma Cancer Introduction
13.3.4 Merck Revenue in Melanoma Cancer Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Melanoma Cancer Introduction
13.4.4 Novartis Revenue in Melanoma Cancer Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Pierre Fabre
13.5.1 Pierre Fabre Company Details
13.5.2 Pierre Fabre Business Overview
13.5.3 Pierre Fabre Melanoma Cancer Introduction
13.5.4 Pierre Fabre Revenue in Melanoma Cancer Business (2015-2020)
13.5.5 Pierre Fabre Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Melanoma Cancer Introduction
13.6.4 Amgen Revenue in Melanoma Cancer Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Melanoma Cancer Introduction
13.7.4 AstraZeneca Revenue in Melanoma Cancer Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Details
13.8.2 Bristol-Myers Squibb Business Overview
13.8.3 Bristol-Myers Squibb Melanoma Cancer Introduction
13.8.4 Bristol-Myers Squibb Revenue in Melanoma Cancer Business (2015-2020)
13.8.5 Bristol-Myers Squibb Recent Development
13.9 Daiichi Sankyo
13.9.1 Daiichi Sankyo Company Details
13.9.2 Daiichi Sankyo Business Overview
13.9.3 Daiichi Sankyo Melanoma Cancer Introduction
13.9.4 Daiichi Sankyo Revenue in Melanoma Cancer Business (2015-2020)
13.9.5 Daiichi Sankyo Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
AB Sciences、Incyte、Merck、Novartis、Pierre Fabre、Amgen、AstraZeneca、Bristol-Myers Squibb、Daiichi Sankyo
【免責事項】
https://www.globalresearch.jp/disclaimer